Drugs

People Are Using Fitbits and Apple Watches to Monitor Their Heart Rate When Binging on Drugs

Christina Farr, writing for CNBC:

It isn't likely to come up in casual face-to-face conversation, but scores of users on Reddit forums, Twitter and other social media sites write about the value of their Fitbit or Apple Watch in tracking their use of cocaine, ketamine, speed, and other drugs. Dozens of these threads have popped up in the past few years on the topic, some focused on cocaine and others on MDMA, also known as ecstasy.

This is the first I've heard about people employing wearable technologies like Fitbits and Apple Watches to monitor their vital signs while under the influence of mind-altering substances. I would argue that this is a good thing, because it obviously highlights the potential negative physical effects of using some of these drugs, and if it helps a drug user understand what is happening in their body, that's a step in the right direction.

There's even a YouTube channel called DrugsLab with more than half a million subscribers. Three hosts perform on-camera tests of drugs suggested by commentators, while their heart rate and body temperature are tracked on a board behind them. The idea, they say, is to promote drug education for millennials.

I haven't mentioned it on the blog before, but DrugsLab is excellent—you should definitely check it out if you haven't already.

But don't expect your doctor to condone the practice. Academics and medical professionals told CNBC that people who rely on a heart rate monitor to protect them from overdosing or from other ill effects of hardcore drugs are giving themselves a false sense of security.

No surprise there. Doctors are simply not going to suggest that patients use these consumer-grade technologies to prevent drug-related casualties, just like they don't encourage or support the use of illicit substances in general. They have reputations to maintain and must protect themselves and their institutions from being sued by patients (or family members of deceased patients) who place so much faith in their Apple Watches that they think it will enable them to safely use drugs without experiencing harm.

However, that doesn't mean that this form of harm reduction should be avoided altogether—just that academics and medical professionals are not going to endorse this practice. At least not for now.


Caffeine Use Disorder

Csilla Ágoston, Róbert Urbán, Mara J. Richman & Zsolt Demetrovics, writing for Science Trends:

According to our results, one of the most important aspects of caffeine use disorder is suffering from the symptoms, which was the most capable in discriminating people with lower and higher level of caffeine use disorder, and it was also the third most severe criterion. The two most severe symptoms were failure to fulfill obligations (e. g.  work, school or home responsibilities) and social/interpersonal problems because of caffeine consumption; these symptoms mostly occurred on the higher end of caffeine use disorder continuum. This means that although caffeine consumption is a socially acceptable habit, caffeine use can interfere with social or occupational functioning for some individuals.

In contrast, the significant amount of time spent with consuming or obtaining caffeine was the least discriminating criterion, which means that the probability of a positive response at lower levels is nearly the same as it is at higher levels. This low level of discriminative value can be the consequence of the high and legal availability of caffeine compared to other substances. The presence of consumption of more caffeine or longer than intended and craving were likely even in case of lower levels of CUD, therefore, these are considered to be less severe symptoms and do not indicate problematic caffeine consumption. Tolerance (which means that the user have to consume more caffeine to reach the same effect or the same dosage cannot induce the same effect anymore), unsuccessful quitting attempts, caffeine use despite negative consequences and attempts to avoid withdrawal symptoms were moderately severe symptoms and had moderate discriminative values.

For many years I've noticed that most people drastically misunderstand their beloved daily stimulant and rush to downplay its negative effects, so it's great to see that caffeine's abuse potential is being studied now.


Book Review - Dreamland

Dreamland.png

The United States of America is in the midst of a widespread opiate epidemic that has devastated hundreds of small rural towns and suburbs across the country. The captivating story of exactly how this came to be is expertly told in acclaimed journalist Sam Quinones' fantastic book, Dreamland: The True Tale of America's Opiate Epidemic, which was published in 2015.

In Dreamland, Quinones magnificently blends together two seemingly-independent narratives: the overly generous prescription of pain medications during the 1990s (including Purdue Pharma's ambitious campaign to aggressively market and sell OxyContin) and the unforeseen—and unprecedented—arrival of cheap, consistent, high quality black tar heroin from one small county in Mexico. According to Quinones, these developments joined forces in a dangerous synergy that ultimately resulted in America's modern-day opiate epidemic.

The book opens with a ridiculously thorough timeline that begins with the distillation of morphine in 1804, moves on to the invention of the hypodermic syringe in 1853 (did you know that the inventor's wife was the first to die of injected drug overdose?), glances at the release of OxyContin in 1996, and ends with the FDA's 2014 approval of Targiniq ER, which combined timed-release oxycodone with naloxone. This timeline, which provides plenty of insight into what went on in between those four events, sets the stage for the book's narrative and successfully primes the reader for the information that follows.

And the actual book doesn't disappoint, either—as the dust-jacket blurb states, it introduces "a memorable cast of characters—pharma pioneers, young Mexican entrepreneurs, narcotics investigators, survivors, and parents, and Quinones shows how these tales fit together." Sure enough, about midway through Dreamland, the reader begins to see the sophisticated web that was woven by several groups of people who were simply following the capitalist dream (operating in their own best interest in an attempt to make as much money as possible), and the once-hidden connections between the people and places involved become as clear as crystal.

When it comes down to it, Dreamland is the best book that I've read so far this year. The story is compelling and unfolds beautifully, in a masterful manner that constantly tempts the reader to read the next chapter. The level of detail that is crammed into each page is truly impressive, but never overwhelming. Simply put—I enjoyed every single word. The topic isn't necessarily the most popular (for the average reader), so I'm not sure that I would recommend this book to someone unless they're already interested in America's opiate epidemic. However, if you are at all intrigued by the topic, then I wholeheartedly recommend this book to you. It will likely take a while to read, because it is packed so densely, but it will be worth your investment of money, time, and energy. And I will keep an eye out for any future books and articles by Quinones, as his writing is an absolute joy to read.

5/5 stars. 385 pages.

Banner image by jplenio, courtesy of Creative Commons licensing.

FDA Monitors Social Media for Drug Abuse Trends

Pat Anson, writing for Pain News Network:

The FDA began monitoring social media – what it calls “proactive pharmacovigilance” – about a decade ago, primarily as an early warning system for adverse events involving medication.

I wasn't aware of this online monitoring by the FDA until now, but it makes sense that they're doing it. Maybe the organization has observed the fact that coverage about drugs (including psychedelics) has become more favorable in the media during the last 10 years.

It's also telling that the FDA seems to be going specifically after kratom vendors.


Go Take the 2018 Global Drug Survey

Image by andibreit, courtesy of Creative Commons licensing.

Image by andibreit, courtesy of Creative Commons licensing.

The Global Drug Survey has been collecting useful and enlightening drug usage data since 2014, and has recently launched its 2018 Global Drug Survey.

From GDS' About Us page:

"GDS is an independent research company based in London. We produce reports for global media, public health and corporate organisations. GDS use its data and expertise to create digital health applications delivering screening and brief interventions for drugs and alcohol. We create free online harm reduction resources and anonymous, confidential self-assessment tools. GDS also produces a range of drug education materials for health and legal professionals, the entertainment industry and the general public.

GDS aims to make drug use safer, regardless of the legal status of the drug, by sharing information with individuals, communities, health and policy organisations.

Using anonymous online research methods Global Drug Survey runs an annual survey in 10 languages, which is hosted by partners in over 20 countries. We work with global media giants around the world who act as hubs to promote our survey and our findings, ensuring that the first people to see the results are the general public.

Survey findings are frank, honest, and revealing. GDS explores the positives and negatives of drug use and detects new drugs trends as soon as they appear. GDS has a unique insight into personal decision-making about drug use . Our international networks of researchers and specialists have extensive experience in data analysis and report writing."

I have already submitted my survey, and highly suggest that you do the same by clicking here. The survey period will remain open until December 31st, 2017, at which time it will be closed and no longer accepting responses.